3-V Bioscience-2640
2006432
Phase 2 small_molecule completed
Quick answer
3-V Bioscience-2640 for Metabolic Syndrome is a Phase 2 program (small_molecule) at Sagimet Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sagimet Biosciences
- Indication
- Metabolic Syndrome
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed